Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 1,624 More Arrow 2,650 Less Arrow 1,464
Earnings before taxes -73,620 Less Arrow -88,979 Less Arrow -94,180
EBITDA -73,794 Less Arrow -97,536 Less Arrow -99,557
Total assets 58,484 More Arrow 146,055 More Arrow 242,493
Current assets 19,436 More Arrow 107,498 More Arrow 199,678
Current liabilities 8,442 More Arrow 25,070 Less Arrow 18,255
Equity capital 49,924 More Arrow 120,856 More Arrow 223,836
- share capital 23,422 Less Arrow 23,302 More Arrow 25,141
Employees (average) 23 Less Arrow 22 Less Arrow 20

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 85.4% Less Arrow 82.7% More Arrow 92.3%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -123.1% More Arrow -59.1% More Arrow -38.2%
Current ratio 230.2% More Arrow 428.8% More Arrow 1093.8%
Return on equity (ROE) -147.5% More Arrow -73.6% More Arrow -42.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 1 More Arrow 2 More Arrow 9
Chg. No. of employees % 5% More Arrow 10% More Arrow 82%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.